GAL-021

N/A

Report date: 2023/11/09 10:00:47

NME

Base Information

Drug NameGAL-021

Drug Alias NameGAL-021

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNitric oxide donorsCalcium-activated potassium channel alpha/beta 1 blockers

TargetsCalcium-activated potassium channel alpha/beta 1

Therapy Area/IndicationsRespiratory Insufficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesGalleon

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGalleon

Active IndicationsN/A

Inactive IndicationsRespiratory Insufficiency

ATC CodeN/A